Ticagrelor: Your Ally Against Cardiovascular Events
Discover the power of this advanced antiplatelet medication in safeguarding your heart and brain health.
Get a Quote & SampleProduct Core Value
Ticagrelor
Ticagrelor is a vital pharmaceutical chemical used to prevent serious cardiovascular events. It functions as a P2Y12 receptor antagonist, effectively inhibiting platelet aggregation. This action is critical in reducing the risk of heart attack and stroke for individuals with conditions such as acute coronary syndrome or coronary artery disease.
- Learn about the precise ticagrelor mechanism of action in preventing dangerous blood clots.
- Understand why ticagrelor for acute coronary syndrome is a cornerstone of modern cardiac care.
- Explore the benefits of using ticagrelor P2Y12 receptor antagonist therapy to maintain blood flow.
- Find out where to buy ticagrelor raw material for research and development purposes.
Key Advantages
Enhanced Cardiovascular Protection
Ticagrelor significantly lowers the risk of heart attack and stroke, offering crucial protection for patients with established cardiovascular disease, as detailed in studies on its role in preventing stroke with ticagrelor.
Effective Platelet Inhibition
As a potent ticagrelor P2Y12 receptor antagonist, it provides rapid and reversible inhibition of platelet activation, ensuring timely and effective antiplatelet therapy.
High Purity Pharmaceutical Grade
Available as a high-purity white or off-white powder, this ticagrelor pharmaceutical grade product meets stringent quality standards for research and development.
Key Applications
Acute Coronary Syndrome (ACS) Management
Essential for patients experiencing ACS, helping to prevent secondary thrombotic events. Researching where to buy ticagrelor raw material is crucial for API manufacturers.
Coronary Artery Disease (CAD)
Reduces the risk of a first heart attack or stroke in individuals with CAD, highlighting the importance of understanding ticagrelor CAS 274693-27-5 for chemical identification.
Stroke Prevention
Used to lower the chance of stroke in patients with acute ischemic stroke or high-risk transient ischemic attack, making the study of ticagrelor mechanism of action vital.
Stent Thrombosis Prevention
Minimizes the risk of blood clots forming in stents used to treat ACS, reinforcing the need for reliable suppliers of ticagrelor pharmaceutical grade.